Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disorders

20 Jan 2025

Abstract excerpt

A wide variety of immunomodulatory therapies are already available for the treatment of multiple sclerosis (MS). Through fundamental insights from basic research with a gain of knowledge in the pathological processes underlying MS, the exploration of additional medical compounds within clinical trials has been ignited. Emerging novel medications with innovative mechanisms of action are being introduced. Those...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Lymphocytic Leukemia Research
Share to Cytokine Signaling Pathways and Interactions
Share to Protein Tyrosine Phosphatases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39842533
DOI: 10.1016/j.autrev.2025.103754

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Disease-modifying strategies: Targeting protein kinases in multiple sclerosis and other autoimmune disordersPMID 39842533Read ↗

Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis.Semantic proximity Read ↗

[MS update: risk factors, diagnosis and treatment].Semantic proximity Read ↗

Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseasesSemantic proximity Read ↗

Emerging small-molecule treatments for multiple sclerosis: focus on B cellsSemantic proximity Read ↗

JAK3 inhibitors for the treatment of inflammatory and autoimmune diseases: a patent review (2016–present)Semantic proximity Read ↗

Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study.Semantic proximity Read ↗

JAK Kinases in Health and Disease: An UpdateSemantic proximity Read ↗

Establishment of comorbidity target pools and prediction of drugs candidate for multiple sclerosis and autoimmune thyroid diseases based on GWAS and transcriptome data.Semantic proximity Read ↗

An investigation of novel therapeutic strategies for the treatment of multiple sclerosis and autoimmunitySemantic proximity Read ↗

Implications for multiple sclerosis in the era of the Affordable Care Act: an evolving treatment paradigm.Semantic proximity Read ↗

United Europeans for development of pharmacogenomics in multiple sclerosis network.Semantic proximity Read ↗

Multiple sclerosis: a practical overview for clinicians.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.